# FDA drug recall: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Exten

> recall · VERIFIED · 2026-06-26

Firm: Lannett Company Inc. · Class II · Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

- Company: Lannett Company Inc.
- Sector: therapeutics
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.